Skip to main content

Navigation group

Type at least 3 characters
397 articles

Articles

Original Research

Published on 15 May 2024

Phase II trial of vaccination with autologous, irradiated melanoma cells engineered by adenoviral mediated gene transfer to secrete granulocyte-macrophage colony stimulating factor in patients with stage III and IV melanoma

in Skin Cancer

  • Tamara A. Sussman
  • Mariano Severgnini
  • Anita Giobbie-Hurder
  • Philip Friedlander
  • Scott J. Swanson
  • Michael Jaklitsch
  • Thomas Clancy
  • Laura A. Goguen
  • David Lautz
  • Richard Swanson
Phase II trial of vaccination with autologous, irradiated melanoma cells engineered by adenoviral mediated gene transfer to secrete granulocyte-macrophage colony stimulating factor in patients with stage III and IV melanoma
Frontiers in Oncology
doi 10.3389/fonc.2024.1395978
  • 1,380 views